✦ LIBER ✦

Ustekinumab in patients with active psoriatic arthritis: Results of the phase III, multicenter, double-blind, placebo-controlled PSUMMIT I study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ustekinumab in active psoriatic arthriti

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy and safety of ustekinumab in pa

✍ McInnes, Iain B; Kavanaugh, Arthur; Gottlieb, Alice B; Puig, Lluís; Rahman, Prot 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 355 KB

Ustekinumab Improves Arthritis-Related A

✍ Kavanaugh, A.; McInnes, I.; Gottlieb, A.; Puig, L.; Rahman, P.; Ritchlin, C.; Li 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Oral apremilast in the treatment of acti

✍ Georg Schett; Jurgen Wollenhaupt; Kim Papp; Rik Joos; Jude F. Rodrigues; Adele R 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Safety of efalizumab in patients with ps

✍ Kim Papp; Phil Mease; Marvin Garovoy; David Zhang 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Abatacept in the treatment of patients w

✍ Philip Mease; Mark C. Genovese; Geoffrey Gladstein; Alan J. Kivitz; Christopher 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views